Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001452482) titled 'Evaluating the effectiveness of the Gro Health mobile app to improve cardiometabolic health in people with type 2 diabetes in Australia' on Dec. 19, 2025.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: RMIT University
Condition:
Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes Mellitus (T2DM)
Metabolic and Endocrine - Diabetes
Public Health - Health service research
Intervention:
Intervention: Gro Health mobile app plus standard care
Materials: Participan...